ترغب بنشر مسار تعليمي؟ اضغط هنا

Development of Computable Phenotype to Identify and Characterize Transitions in Acuity Status in Intensive Care Unit

101   0   0.0 ( 0 )
 نشر من قبل Azra Bihorac
 تاريخ النشر 2020
والبحث باللغة English
 تأليف Yuanfeng Ren




اسأل ChatGPT حول البحث

Background: In the United States, 5.7 million patients are admitted annually to intensive care units (ICU), with costs exceeding $82 billion. Although close monitoring and dynamic assessment of patient acuity are key aspects of ICU care, both are limited by the time constraints imposed on healthcare providers. Methods: Using the University of Florida Health (UFH) Integrated Data Repository as Honest Broker, we created a database with electronic health records data from a retrospective study cohort of 38,749 adult patients admitted to ICU at UF Health between 06/01/2014 and 08/22/2019. This repository includes demographic information, comorbidities, vital signs, laboratory values, medications with date and timestamps, and diagnoses and procedure codes for all index admission encounters as well as encounters within 12 months prior to index admission and 12 months follow-up. We developed algorithms to identify acuity status of the patient every four hours during each ICU stay. Results: We had 383,193 encounters (121,800 unique patients) admitted to the hospital, and 51,073 encounters (38,749 unique patients) with at least one ICU stay that lasted more than four hours. These patients requiring ICU admission had longer median hospital stay (7 days vs. 1 day) and higher in-hospital mortality (9.6% vs. 0.4%) compared with those not admitted to the ICU. Among patients who were admitted to the ICU and expired during hospital admission, more deaths occurred in the ICU than on general hospital wards (7.4% vs. 0.8%, respectively). Conclusions: We developed phenotyping algorithms that determined patient acuity status every four hours while admitted to the ICU. This approach may be useful in developing prognostic and clinical decision-support tools to aid patients, caregivers, and providers in shared decision-making processes regarding resource use and escalation of care.



قيم البحث

اقرأ أيضاً

Background: Acute kidney injury (AKI) is a common complication in hospitalized patients and a common cause for chronic kidney disease (CKD) and increased hospital cost and mortality. By timely detection of AKI and AKI progression, effective preventiv e or therapeutic measures could be offered. This study aims to develop and validate an electronic phenotype to identify patients with CKD and AKI. Methods: A database with electronic health records data from a retrospective study cohort of 84,352 hospitalized adults was created. This repository includes demographics, comorbidities, vital signs, laboratory values, medications, diagnoses and procedure codes for all index admission, 12 months prior and 12 months follow-up encounters. We developed algorithms to identify CKD and AKI based on the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. To measure diagnostic performance of the algorithms, clinician experts performed clinical adjudication of AKI and CKD on 300 selected cases. Results: Among 149,136 encounters, identified CKD by medical history was 12% which increased to 16% using creatinine criteria. Among 130,081 encounters with sufficient data for AKI phenotyping 21% had AKI. The comparison of CKD phenotyping algorithm to manual chart review yielded PPV of 0.87, NPV of 0.99, sensitivity of 0.99, and specificity of 0.89. The comparison of AKI phenotyping algorithm to manual chart review yielded PPV of 0.99, NPV of 0.95 , sensitivity 0.98, and specificity 0.98. Conclusions: We developed phenotyping algorithms that yielded very good performance in identification of patients with CKD and AKI in validation cohort. This tool may be useful in identifying patients with kidney disease in a large population, in assessing the quality and value of care in such patients.
We introduce a simple approach to understanding the relationship between single nucleotide polymorphisms (SNPs), or groups of related SNPs, and the phenotypes they control. The pipeline involves training deep convolutional neural networks (CNNs) to d ifferentiate between images of plants with reference and alterna
Background: Providing appropriate care for people suffering from COVID-19, the disease caused by the pandemic SARS-CoV-2 virus is a significant global challenge. Many individuals who become infected have pre-existing conditions that may interact with COVID-19 to increase symptom severity and mortality risk. COVID-19 patient comorbidities are likely to be informative about individual risk of severe illness and mortality. Accurately determining how comorbidities are associated with severe symptoms and mortality would thus greatly assist in COVID-19 care planning and provision. Methods: To assess the interaction of patient comorbidities with COVID-19 severity and mortality we performed a meta-analysis of the published global literature, and machine learning predictive analysis using an aggregated COVID-19 global dataset. Results: Our meta-analysis identified chronic obstructive pulmonary disease (COPD), cerebrovascular disease (CEVD), cardiovascular disease (CVD), type 2 diabetes, malignancy, and hypertension as most significantly associated with COVID-19 severity in the current published literature. Machine learning classification using novel aggregated cohort data similarly found COPD, CVD, CKD, type 2 diabetes, malignancy and hypertension, as well as asthma, as the most significant features for classifying those deceased versus those who survived COVID-19. While age and gender were the most significant predictor of mortality, in terms of symptom-comorbidity combinations, it was observed that Pneumonia-Hypertension, Pneumonia-Diabetes and Acute Respiratory Distress Syndrome (ARDS)-Hypertension showed the most significant effects on COVID-19 mortality. Conclusions: These results highlight patient cohorts most at risk of COVID-19 related severe morbidity and mortality which have implications for prioritization of hospital resources.
With the development of the Internet of Things(IoT) and Artificial Intelligence(AI) technologies, human activity recognition has enabled various applications, such as smart homes and assisted living. In this paper, we target a new healthcare applicat ion of human activity recognition, early mobility recognition for Intensive Care Unit(ICU) patients. Early mobility is essential for ICU patients who suffer from long-time immobilization. Our system includes accelerometer-based data collection from ICU patients and an AI model to recognize patients early mobility. To improve the model accuracy and stability, we identify features that are insensitive to sensor orientations and propose a segment voting process that leverages a majority voting strategy to recognize each segments activity. Our results show that our system improves model accuracy from 77.78% to 81.86% and reduces the model instability (standard deviation) from 16.69% to 6.92%, compared to the same AI model without our feature engineering and segment voting process.
Providing computational infrastructure for handling diverse intensive care unit (ICU) datasets, the R package ricu enables writing dataset-agnostic analysis code, thereby facilitating multi-center training and validation of machine learning models. T he package is designed with an emphasis on extensibility both to new datasets as well as clinical data concepts, and currently supports the loading of around 100 patient variables corresponding to a total of 319,402 ICU admissions from 4 data sources collected in Europe and the United States. By allowing for the addition of user-specified medical concepts and data sources the aim of ricu is to foster robust, data-based intensive care research, allowing the user to externally validate their method or conclusion with relative ease, and in turn facilitating reproducible and therefore transparent work in this field.

الأسئلة المقترحة

التعليقات
جاري جلب التعليقات جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
mircosoft-partner

هل ترغب بارسال اشعارات عن اخر التحديثات في شمرا-اكاديميا